BAF53A Recombinant Antibody, Cy3 Conjugated
Product Specifications
Background
Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology) . Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner.
Synonyms
ACTL6; ACTL6A; Arp4; ArpNbeta; BAF53; BAF53A; hArpN beta; INO80K.
Gene ID
86
Swiss Prot
O96019
Cellular Locus
Nucleus
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Target
BAF53A
Clonality
Recombinant
Conjugation
Cy3
Source
KLH conjugated synthetic peptide derived from human ACTL6A
Applications
WB, IF
Purification
Purified by Protein A.
Excitation Emission
512,550nm/570,615nm
Concentration
Lot dependent
Dilution
WB (1:300-5000), IF ()
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Product Datasheet
https://www.biossantibodies.com/datasheets/bsm-61726R-Cy3
Gene ID URL
86
Isotype
IgG
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1457471-01 0.02 mg (E-Coli)
Recombinant Bordetella pertussis Tryptophan 2,3-dioxygenase (kynA)
Ask
View Details 
MBS1457471-02 0.02 mg (Yeast)
Recombinant Bordetella pertussis Tryptophan 2,3-dioxygenase (kynA)
Ask
View Details MBS1457471-03 0.1 mg (E-Coli)
Recombinant Bordetella pertussis Tryptophan 2,3-dioxygenase (kynA)
Ask
View Details